Variables | Numbers of patients | p | ||
---|---|---|---|---|
USP53 high expression | USP53 low expression | |||
Age | Â | |||
≥ 50 | 16 | 35 | 0.13036 | |
< 50 | 11 | 11 | ||
Tumor size | Â | Â | Â | |
≥ 2 cm | 18 | 36 | 0.27575 | |
< 2 cm | 9 | 10 | ||
Grade | Â | |||
G1/G2 | 24 | 35 | 0.17984 | |
G3 | 3 | 11 | ||
TNM stage | Â | |||
I-II | 27 | 37 | 0.03698 | |
III | 0 | 9 | ||
ER | Â | |||
negative | 1 | 1 | > 0.9999 | |
positive | 26 | 45 | ||
PR | Â | |||
negative | 9 | 20 | 0.39246 | |
positive | 18 | 26 | ||
HER2 | Â | |||
negative | 15 | 32 | 0.22753 | |
positive | 12 | 14 | ||
Ki-67 | Â | |||
< 14% | 5 | 7 | 0.96784 | |
≥ 14% | 22 | 39 | ||
Axillary lymph nodes | Â | |||
negative | 20 | 28 | 0.25106 | |
positive | 7 | 18 |